immune system
|
• worse than in Faslpr homozygotes
|
|
• compared with Faslpr homozygotes
|
|
• mice exhibit IgG deposits in the kidney unlike wild-type mice
|
|
• compared with Faslpr homozygotes
|
|
• compared with Faslpr homozygotes
|
|
• compared with Faslpr homozygotes
|
|
• mice exhibit increased serum levels of kappa-chain rheumatoid factor and DNA auto-antibodies, lymphadenopathy, glomerulonephritis, renal immunoglobulin deposits, proteinuria, and end organ disease compared to in wild-type mice
• some systemic lupus erythematosus symptoms are more severe than Faslpr homozygotes
|
|
• mice exhibit increased serum levels of kappa-chain rheumatoid factor compared to in wild-type mice and Faslpr homozygotes
|
|
• DNA auto-antibodies are increased compared to in wild-type mice at 12 weeks
|
renal/urinary system
homeostasis/metabolism
endocrine/exocrine glands
|
• worse than in Faslpr homozygotes
|
digestive/alimentary system
|
• worse than in Faslpr homozygotes
|
hematopoietic system
|
• compared with Faslpr homozygotes
|
|
• mice exhibit IgG deposits in the kidney unlike wild-type mice
|
|
• compared with Faslpr homozygotes
|
|
• compared with Faslpr homozygotes
|
|
• compared with Faslpr homozygotes
|


Analysis Tools